Allergic Conjunctivitis - Pipeline Review, H2 2015

1
Allergic Conjunctivitis - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Allergic Conjunctivitis
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Allergic
  Conjunctivitis and enlists all their major and
  minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Allergic Conjunctivitis products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Allergic Conjunctivitis pipeline
  on the basis of target, MoA, route of
  administration and molecule type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/allergi
  c-conjunctivitis-pipeline-review-h2-2015-market

3


Table of Content
List of Figures Number of Products under
Development for Allergic Conjunctivitis, H2 2015
8 Number of Products under Development by
Companies, H2 2015 9 Comparative Analysis by
Clinical Stage Development, H2 2015
11 Comparative Analysis by Early Stage Products,
H2 2015 12 Assessment by Monotherapy Products, H2
2015 26 Number of Products by Top 10 Targets, H2
2015 27 Number of Products by Stage and Top 10
Targets, H2 2015 27 Number of Products by
Mechanism of Actions, H2 2015 29 Number of
Products by Stage and Mechanism of Actions, H2
2015 29 Number of Products by Routes of
Administration, H2 2015 31 Number of Products by
Stage and Routes of Administration, H2 2015
31 Number of Products by Molecule Types, H2 2015
33 Number of Products by Stage and Molecule
Types, H2 2015 33
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Allergic Conjunctivitis Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Allergic Conjunctivitis pipeline
depth and focus of Indication therapeutics Develop
and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/allergic-conjunctiviti
s-pipeline-review-h2-2015-market/enquire-about-rep
ort
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/allergic-conjunctiviti
s-pipeline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com